Five-Year Outcomes of FOLFIRINOX vs Gemcitabine as Adjuvant Therapy for Pancreatic CancerThierry Conroy, Jean François Seitz, Emmanuel Mitry et al.|JAMA Oncology|2022Cited by 322
An update on treatment options for pancreatic adenocarcinomaAurélien Lambert, Thierry Conroy, Lilian Schwarz et al.|Therapeutic Advances in Medical Oncology|2019Cited by 211
Current standards and new innovative approaches for treatment of pancreatic cancerThierry Conroy, Michel Ducreux, Jean‐Baptiste Bachet et al.|European Journal of Cancer|2016Cited by 186